Share of global pharmaceutical industry by gross value added by region 2014

This statistic displays the regional breakdown of the gross value added in the global pharmaceutical industry in 2014. During this year, Europe accounted for 31.5 percent of the gross value added in the industry. The pharmaceutical industry employs around five million people across the globe, with about 3.4 million employees located in Asia.

Distribution of gross value added in the global pharmaceutical industry in 2014, by region*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until June 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

February 2017

Region

Worldwide

Survey time period

2014

Supplementary notes

* All values were calculated based on given data in U.S. dollars. The source gives no information about the remaining percentage to add up 100 percent.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Coronavirus: the pharma and medtech response"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.